SRC-3 treatment decreased tumor growth in a Jeko-1 ibrutinib resistant mouse model. by Imani Bijou (18275174)

Primary endpoint analysis, i.e., time to first occurrence of combined event of 50% decrease in eGFR or ESRD. by Rozita Mohd (7411322)

Pathogenicity of LCLs in 5-week-old NOG mice. by Ken Sagou (1945318)

Effect of melatonin (50 μM) on the TGF-β1 (10 ng/mL, 72 h)-mediated TGF-β1/Smad pathway and EMT in HBdSMCs. by Yang Zhang (30734)

M344 decreases orthotopic pancreatic tumor growth when used as a treatment alone or in combination with gemcitabine. by Shelby M. Knoche (13833807)

Biochar decreases nutrient leaching in KCl-fertilized Podzols grown with black mucuna by Luciana Aparecida Rodrigues (7291115)

Affinity analysis results (with a confidence level above 50%). by Marta R. Jabłońska (8491404)

Association between CVR components^b'*' and depressive status (BDI-II ≥18) in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

Subjects:

Baseline characteristics of the study participants. by Sandra Martín-Peláez (11353470)

Subjects:

Flow chart for the analysis of cardiovascular risk and depression in the PREDIMED-PLUS trial. by Sandra Martín-Peláez (11353470)

Subjects:

PPM1A facilitates both nuclear distribution and transcription potency of YAP/TAZ. by Ruyuan Zhou (10197187)

“…<b>(B–D)</b> Transcription potency of YAP (5 ng), which was suppressed by coexpression of MST1 (50 ng) (B), LATS1 (500 ng) (C), or MAP4K1 (50 ng) (D), was markedly recovered by cotransfection of wild-type PPM1A but not the enzyme-dead PPM1A (D239N). …”

BIC of models tested throughout model building. by Guillaume Lingas (9955528)

Subjects:

Pharmacokinetic models and concentrations predictions of treatments considered. by Guillaume Lingas (9955528)

Subjects:

Mutagenesis model simulations. by Guillaume Lingas (9955528)

Subjects:

SMC-specific knockout of Klf5 (smcKlf5^−/−) exacerbates the progression of Ang II–induced AAA by facilitating ROS formation. by Dong Ma (584680)

Oral administration of TVSE decreases angiogenesis in 4T1 tumors in BALB/c mice. by Hyun Sook Lee (8039876)

Decreased expression of Rho in the <i>nrl</i>-KO retinas as detected by dot blotting. by Fei Liu (21082)

Growth of cell monolayers and 3D spheroids under different concentrations of HIF inhibitor YC-1 in growth media. by Sreerupa Sarkar (9628788)

WT1 siRNA decreases proliferation, pAKT, and Bcl2 expression. by Ayana E. Morales (17756335)

“…<b>C.</b> RT-qPCR of WT1, p<0.05(*), vFLIP(ns), LANA, p<0.0001(****), K8.1, p<0.0001(****), and BCL2 p<0.05(*) in the setting of WT1 knockdown in ISLK BAC-16 with WT1 siRNA in comparison to a control siRNA using two-sided, unpaired student’s t-tests. …”

Expression of ApoB-50 decreased lipid accumulation and inhibited HCV production. by Bei Wang (116772)